Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Journal of the National Cancer Institute
|
June 10, 2020
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
Marco Bandini, Jeffrey S Ross, Daniele Raggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 25, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus
Alexa B Schrock, Dean Pavlick, Samuel J Klempner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2018
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
Andrea Necchi, Andrea Anichini, Daniele Raggi, et al.
European Urology Focus
|
July 21, 2018
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy
Andrea Necchi, Gennady Bratslavsky, Robert J Corona, et al.
Clinical Genitourinary Cancer
|
March 8, 2020
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study
Marco Bandini, Filippo Pederzoli, Russell Madison, et al.
European Urology
|
November 12, 2019
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies
Andrea Necchi, Daniele Raggi, Andrea Gallina, et al.
Journal of Gastrointestinal Oncology
|
October 12, 2019
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy
Gerald Li, Dean Pavlick, Jon H Chung, et al.
Nature Communications
|
November 18, 2018
RET rearrangements are actionable alterations in breast cancer
Bhavna S Paratala, Jon H Chung, Casey B Williams, et al.
European Urology
|
December 29, 2019
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study
Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al.
JCO Precision Oncology
|
February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study
Steven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Journal of the National Cancer Institute
|
June 10, 2020
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
Marco Bandini, Jeffrey S Ross, Daniele Raggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 25, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus
Alexa B Schrock, Dean Pavlick, Samuel J Klempner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2018
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
Andrea Necchi, Andrea Anichini, Daniele Raggi, et al.
European Urology Focus
|
July 21, 2018
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy
Andrea Necchi, Gennady Bratslavsky, Robert J Corona, et al.
Clinical Genitourinary Cancer
|
March 8, 2020
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study
Marco Bandini, Filippo Pederzoli, Russell Madison, et al.
European Urology
|
November 12, 2019
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies
Andrea Necchi, Daniele Raggi, Andrea Gallina, et al.
Journal of Gastrointestinal Oncology
|
October 12, 2019
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy
Gerald Li, Dean Pavlick, Jon H Chung, et al.
Nature Communications
|
November 18, 2018
RET rearrangements are actionable alterations in breast cancer
Bhavna S Paratala, Jon H Chung, Casey B Williams, et al.
European Urology
|
December 29, 2019
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study
Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al.
JCO Precision Oncology
|
February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study
Steven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Page
of 5